Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography

References

• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. doi:10.1007/BF003088091759558
   PubMed Web of Science ®Google Scholar
• Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791–1800. doi:10.1212/WNL.58.12.179112084879
   PubMed Web of Science ®Google Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269. doi:10.1016/j.jalz.2011.03.00521514250
   PubMed Web of Science ®Google Scholar
• Jack CR Jr., Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207–216. doi:10.1016/S1474-4422(12)70291-023332364
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356. doi:10.1126/science.107299412130773
   PubMed Web of Science ®Google Scholar
• Thal DR. The pre-capillary segment of the blood-brain barrier and its relation to perivascular drainage in Alzheimer’s disease and small vessel disease. Sci World J. 2009;9:557–563. doi:10.1100/tsw.2009.72
   Web of Science ®Google Scholar
• Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science. 2010;330(6012):1774. doi:10.1126/science.119762321148344
   PubMed Web of Science ®Google Scholar
• Kress BT, Iliff JJ, Xia M, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76(6):845–861. doi:10.1002/ana.2427125204284
   PubMed Web of Science ®Google Scholar
• Kuo YM, Crawford F, Mullan M, et al. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer’s disease. Mol Med. 2000;6(5):430–439. doi:10.1007/BF0340178510952022
   PubMed Web of Science ®Google Scholar
• Potter R, Patterson BW, Elbert DL, et al. Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med. 2013;5(189):189ra177. doi:10.1126/scitranslmed.3005615
   Web of Science ®Google Scholar
• Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol. 2008;18(2):253–266. doi:10.1111/j.1750-3639.2008.00133.x18363936
   PubMed Web of Science ®Google Scholar
• Attems J, Yamaguchi H, Saido TC, Thal DR. Capillary CAA and perivascular Abeta-deposition: two distinct features of Alzheimer’s disease pathology. J Neurol Sci. 2010;299(1–2):155–162. doi:10.1016/j.jns.2010.08.03020850138
   PubMed Web of Science ®Google Scholar
• Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer’s disease. Am J Pathol. 1998;153(3):725–733. doi:10.1016/S0002-9440(10)65616-79736023
   PubMed Web of Science ®Google Scholar
• Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO. Capillary and arterial cerebral amyloid angiopathy in Alzheimer’s disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol. 2003;29(2):106–117. doi:10.1046/j.1365-2990.2003.00424.x12662319
   PubMed Web of Science ®Google Scholar
• Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra111. doi:10.1126/scitranslmed.3003748
   PubMed Web of Science ®Google Scholar
• Nedergaard M. Neuroscience. Garbage truck of the brain. Science. 2013;340(6140):1529–1530. doi:10.1126/science.124051423812703
   PubMed Web of Science ®Google Scholar
• Peng W, Achariyar TM, Li B, et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease. Neurobiol Dis. 2016;93:215–225. doi:10.1016/j.nbd.2016.05.01527234656
   PubMed Web of Science ®Google Scholar
• Iliff JJ, Lee H, Yu M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013;123(3):1299–1309. doi:10.1172/JCI6767723434588
   PubMed Web of Science ®Google Scholar
• Iliff JJ, Chen MJ, Plog BA, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci. 2014;34(49):16180–16193. doi:10.1523/JNEUROSCI.3020-14.201425471560
   PubMed Web of Science ®Google Scholar
• Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005–1007. doi:10.1126/science.118096219779148
   PubMed Web of Science ®Google Scholar
• Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373–377. doi:10.1126/science.124122424136970
   PubMed Web of Science ®Google Scholar
• Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a ‘paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 1985;326(1):47–63. doi:10.1016/0006-8993(85)91383-63971148
   PubMed Web of Science ®Google Scholar
• Rennels ML, Blaumanis OR, Grady PA. Rapid solute transport throughout the brain via paravascular fluid pathways. Adv Neurol. 1990;52:431–439.2396537
   PubMedGoogle Scholar
• Nilsson C, Stahlberg F, Thomsen C, Henriksen O, Herning M, Owman C. Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging. Am J Physiol. 1992;262(1 Pt 2):R20–24. doi:10.1152/ajpregu.1992.262.1.R201733335
   PubMed Web of Science ®Google Scholar
• Kiviniemi V, Wang X, Korhonen V, et al. Ultra-fast magnetic resonance encephalography of physiological brain activity – Glymphatic pulsation mechanisms? J Cereb Blood Flow Metab. 2016;36(6):1033–1045. doi:10.1177/0271678X1562204726690495
   PubMed Web of Science ®Google Scholar
• Gaberel T, Gakuba C, Goulay R, et al. Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke. 2014;45(10):3092–3096. doi:10.1161/STROKEAHA.114.00661725190438
   PubMed Web of Science ®Google Scholar
• Aldea R, Weller RO, Wilcock DM, Carare RO, Richardson G. Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain. Front Aging Neurosci. 2019;11:1. doi:10.3389/fnagi.2019.0000130740048
   PubMed Web of Science ®Google Scholar
• Roher AE, Garami Z, Tyas SL, et al. Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer’s disease. Alzheimers Dement. 2011;7(4):445–455. doi:10.1016/j.jalz.2010.09.00221388892
   PubMed Web of Science ®Google Scholar
• Claassen JA, Diaz-Arrastia R, Martin-Cook K, Levine BD, Zhang R. Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. J Alzheimers Dis. 2009;17(3):621–629. doi:10.3233/JAD-2009-107919433892
   PubMed Web of Science ®Google Scholar
• Stefani A, Sancesario G, Pierantozzi M, et al. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer’s and mixed dementia. J Neurol Sci. 2009;283(1–2):109–115. doi:10.1016/j.jns.2009.02.34319278690
   PubMed Web of Science ®Google Scholar
• Jin WS, Bu XL, Wang YR, et al. Reduced cardiovascular functions in patients with Alzheimer’s disease. J Alzheimers Dis. 2017;58(3):919–925. doi:10.3233/JAD-17008828505975
   PubMed Web of Science ®Google Scholar
• Zuccolo E, Lim D, Kheder DA, et al. Acetylcholine induces intracellular Ca(2+) oscillations and nitric oxide release in mouse brain endothelial cells. Cell Calcium. 2017;66:33–47. doi:10.1016/j.ceca.2017.06.00328807148
   PubMed Web of Science ®Google Scholar
• Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57(6):789–794. doi:10.1002/ana.2049315929050
   PubMed Web of Science ®Google Scholar
• Roher AE, Garami Z, Alexandrov AV, et al. Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer’s disease. Neurol Res. 2006;28(6):672–678. doi:10.1179/016164106X13047016945221
   PubMed Web of Science ®Google Scholar
• Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61(10):1531–1534. doi:10.1001/archneur.61.10.153115477506
   PubMed Web of Science ®Google Scholar
• Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med. 2009;6(11):e1000180. doi:10.1371/journal.pmed.100018019901977
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi:10.1016/S1474-4422(10)70104-620610345
   PubMed Web of Science ®Google Scholar
• Grimmer T, Faust M, Auer F, et al. White matter hyperintensities predict amyloid increase in Alzheimer’s disease. Neurobiol Aging. 2012;33(12):2766–2773. doi:10.1016/j.neurobiolaging.2012.01.01622410648
   PubMed Web of Science ®Google Scholar
• Brickman AM, Guzman VA, Gonzalez-Castellon M, et al. Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated. Neurosci Lett. 2015;592:54–58. doi:10.1016/j.neulet.2015.03.00525748319
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol. 2001;46(1):59–80. doi:10.1016/S0039-6257(01)00234-X11525792
   PubMed Web of Science ®Google Scholar
• Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005;206(4):319–348. doi:10.1111/joa.2005.206.issue-415817102
   PubMed Web of Science ®Google Scholar
• Cooper LS, Wong TY, Klein R, et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke. 2006;37(1):82–86. doi:10.1161/01.STR.0000195134.04355.e516306463
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet. 2001;358(9288):1134–1140. doi:10.1016/S0140-6736(01)06253-511597667
   PubMed Web of Science ®Google Scholar
• Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Amsterdam Vascular Medicine G. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology. 2002;59(10):1536–1540. doi:10.1212/01.WNL.0000033093.16450.5C12451193
   PubMed Web of Science ®Google Scholar
• Ikram MK, Ong YT, Cheung CY, Wong TY. Retinal vascular caliber measurements: clinical significance, current knowledge and future perspectives. Ophthalmologica. 2013;229(3):125–136. doi:10.1159/00034215823006932
   PubMed Web of Science ®Google Scholar
• Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106(12):2269–2280. doi:10.1016/S0161-6420(99)90525-010599656
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA. 2002;287(9):1153–1159. doi:10.1001/jama.287.9.115311879113
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke. 2002;33(6):1487–1492. doi:10.1161/01.STR.0000016789.56668.4312052979
   PubMed Web of Science ®Google Scholar
• de Jong FJ, Schrijvers EM, Ikram MK, et al. Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology. 2011;76(9):816–821. doi:10.1212/WNL.0b013e31820e7baa21288987
   PubMed Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.00821514249
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-61202204
   PubMed Web of Science ®Google Scholar
• Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39(9):1159–1165. doi:10.1212/WNL.39.9.11592771064
   PubMed Web of Science ®Google Scholar
• Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414. doi:10.1212/WNL.43.11.2412-a
   PubMed Web of Science ®Google Scholar
• Iaccarino L, Chiotis K, Alongi P, et al. A cross-validation of FDG- and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting. J Alzheimers Dis. 2017;59(2):603–614. doi:10.3233/JAD-17015828671117
   PubMed Web of Science ®Google Scholar
• Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK. Alzheimer’s disease neuroimaging I. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology. 2011;77(17):1619–1628. doi:10.1212/WNL.0b013e318234331421998317
   PubMed Web of Science ®Google Scholar
• Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–260. doi:10.1212/WNL.43.2.2508094895
   PubMed Web of Science ®Google Scholar
• Planiol T, Pourcelot L, Itti R. The carotid and cerebral circulations. Advances in its study by external physical methods. Principles, normal recordings, adopted parameters. Nouv Presse Med. 1973;2(37):2451–2456.4748647
   PubMedGoogle Scholar
• Gosling RG, King DH. Arterial assessment by Doppler-shift ultrasound. Proc R Soc Med. 1974;67(6 Pt 1):447–449.4850636
   PubMedGoogle Scholar
• Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics. 1997;53(2):567–578. doi:10.2307/25339589192452
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191. doi:10.3758/BF0319314617695343
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. doi:10.3758/BRM.41.4.114919897823
   PubMed Web of Science ®Google Scholar
• Dreha-Kulaczewski S, Joseph AA, Merboldt KD, Ludwig HC, Gartner J, Frahm J. Inspiration is the major regulator of human CSF flow. J Neurosci. 2015;35(6):2485–2491. doi:10.1523/JNEUROSCI.3246-14.201525673843
   PubMed Web of Science ®Google Scholar
• Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487–499. doi:10.1016/S1474-4422(05)70141-116033691
   PubMed Web of Science ®Google Scholar
• Beach TG, Wilson JR, Sue LI, et al. Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. 2007;113(1):13–21. doi:10.1007/s00401-006-0136-y17021755
   PubMed Web of Science ®Google Scholar
• Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology. 2005;64(3):494–500. doi:10.1212/01.WNL.0000150886.50187.3015699381
   PubMed Web of Science ®Google Scholar
• Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M. Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients. J Neurol. 2006;253(1):58–64. doi:10.1007/s00415-005-0926-516096820
   PubMed Web of Science ®Google Scholar
• Rosengarten B, Paulsen S, Burr O, Kaps M. Neurovascular coupling in Alzheimer patients: effect of acetylcholine-esterase inhibitors. Neurobiol Aging. 2009;30(12):1918–1923. doi:10.1016/j.neurobiolaging.2008.02.01718395940
   PubMed Web of Science ®Google Scholar
• Goto I, Katsuki S, Ikui H, Kimoto K, Mimatsu T. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke. 1975;6(3):263–269. doi:10.1161/01.STR.6.3.26350653
   PubMed Web of Science ®Google Scholar
• Walsh JB, Rosen RB, Berinstein DM, ed. Diseases of the Retina. Chapter 13. Systemic Hypertension and the Eye. Duane’s Foundations of clinical Ophthalmology. Hagerstown: Lippincott Williams & Wilkins; 2007. Tasman W JE, ed.
   Google Scholar
• Moss HE. Retinal vascular changes are a marker for cerebral vascular diseases. Curr Neurol Neurosci Rep. 2015;15(7):40. doi:10.1007/s11910-015-0561-126008809
   PubMed Web of Science ®Google Scholar
• Lindley RI, Wang JJ, Wong MC, et al. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol. 2009;8(7):628–634. doi:10.1016/S1474-4422(09)70131-019481977
   PubMed Web of Science ®Google Scholar
• Ikram MK, De Jong FJ, Van Dijk EJ, et al. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain. 2006;129(Pt 1):182–188. doi:10.1093/brain/awh68816317022
   PubMed Web of Science ®Google Scholar